Ascendis Pharma

Ascendis Pharma uses its TransCon technology to develop therapies for endocrinology and oncology. Key products include TransCon PTH and TransCon CNP.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2015
Stage of Initial Investment
Series D
Initial Investment Year
2014
Ascendis Portco Hover Image